Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

C-Section pain study: which block helps moms recover faster?

NCT ID NCT07181902

Symptom relief Sponsor: Elazıg Fethi Sekin Sehir Hastanesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at two types of pain blocks given after a C-section: the erector spinae plane block and the retrolaminar block. Researchers will check how well 60 women recover 24 hours after surgery using a special questionnaire. The goal is to see which block leads to less pain and a smoother recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If one block proves better, it could lead to improved pain management and faster recovery after cesarean sections.
What could go wrong
This is a small, retrospective study, so results may not apply to all patients. The difference between the two blocks might be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study includes adult women undergoing elective cesarean section at Elazığ Fethi Sekin City Hospital. Participants will receive either an Erector Spinae Plane (ESP) block or a Retrolaminar Block (RLB) for postoperative analgesia and will be followed for postoperative recovery quality and pain outcomes.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Women aged 18-45 years, scheduled for elective cesarean delivery under spinal anesthesia. * Gestational age ≥37 weeks, singleton pregnancy. * Undergoing either ESP or RLB for postoperative analgesia. * ASA Physical Status II-III. * Ability to understand and complete ObsQoR-11T questionnaire. * Provided written informed consent prior to participation. Exclusion Criteria * Emergency cesarean delivery. * Multiple pregnancy, preterm delivery (\<37 weeks), * Severe maternal or obstetric complications (e.g., preeclampsia, placenta previa, placenta accreta spectrum), regardless of urgency. * BMI ≥40 kg/m² * Significant systemic diseases (e.g., severe cardiac, respiratory, renal, or hepatic disease). * Fetal or placental anomalies. * History of chronic pain syndromes, opioid dependence, or long-term analgesic use. * Neurological, psychiatric, or cognitive disorders that may interfere with pain perception or questionnaire completion. * Patients who declined participation or did not provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative pain management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postoperative pain management

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Elazığ Fethi Sekin City Hospital

    Elâzığ, Seçiniz, 23100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.